Format

Send to

Choose Destination
See comment in PubMed Commons below
Respir Res. 2002;3:3. Epub 2001 Oct 11.

Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder.

Author information

1
Instituto Nacional de Enfermedades Respiratorias & Facultad de Ciencias, UNAM, México DF, México. mselman@conacyt.mx

Abstract

Idiopathic pulmonary fibrosis is a chronic and usually progressive lung disorder of unknown etiology. A growing body of evidence suggests that, in contrast to other interstitial lung diseases, IPF is a distinct entity in which inflammation is a secondary and non-relevant pathogenic partner. Evidence includes the presence of similar mild/moderate inflammation either in early or late disease, and the lack of response to potent anti-inflammatory therapy. Additionally, it is clear from experimental models and some human diseases that it is possible to have fibrosis without inflammation. An evolving hypothesis proposes that IPF may result from epithelial micro-injuries and abnormal wound healing.

PMID:
11806838
PMCID:
PMC64814
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center